This article needs additional citations for verification. (October 2010)
In genetics, complementary DNA (cDNA) is DNA synthesized from a single-stranded RNA (e.g., messenger RNA (mRNA) or microRNA (miRNA)) template in a reaction catalyzed by the enzyme reverse transcriptase. cDNA is often used to express a specific protein in a cell that does not normally express that protein (i.e., heterologous expression), or to sequence or quantify mRNA molecules using DNA based methods (qPCR, RNA-seq). cDNA that codes for a specific protein can be transferred to a recipient cell for expression, often bacterial or yeast expression systems. cDNA is also generated to analyze transcriptomic profiles in bulk tissue, single cells, or single nuclei in assays such as microarrays, qPCR, and RNA-seq.
cDNA is also produced naturally by retroviruses (such as HIV-1, HIV-2, simian immunodeficiency virus, etc.) and then integrated into the host's genome, where it creates a provirus.
The term cDNA is also used, typically in a bioinformatics context, to refer to an mRNA transcript's sequence, expressed as DNA bases (deoxy-GCAT) rather than RNA bases (GCAU).
RNA serves as a template for cDNA synthesis. In cellular life, cDNA is generated by viruses and retrotransposons for integration of RNA into target genomic DNA. In molecular biology, RNA is purified from source material after genomic DNA, proteins and other cellular components are removed. cDNA is then synthesized through in vitro reverse transcription.
RNA is transcribed from genomic DNA in host cells and is extracted by first lysing cells then purifying RNA utilizing widely-used methods such as phenol-chloroform, silica column, and bead-based RNA extraction methods. Extraction methods vary depending on the source material. For example, extracting RNA from plant tissue requires additional reagents, such as polyvinylpyrrolidone (PVP), to remove phenolic compounds, carbohydrates, and other compounds that will otherwise render RNA unusable. To remove DNA and proteins, enzymes such as DNase and Proteinase K are used for degradation. Importantly, RNA integrity is maintained by inactivating RNases with chaotropic agents such as guanidinium isothiocyanate, sodium dodecyl sulphate (SDS), phenol or chloroform. Total RNA is then separated from other cellular components and precipitated with alcohol. Various commercial kits exist for simple and rapid RNA extractions for specific applications. Additional bead-based methods can be used to isolate specific sub-types of RNA ......(e.g. mRNA and microRNA) based on size or unique RNA regions.
Using a reverse transcriptase enzyme and purified RNA templates, one strand of cDNA is produced (first-strand cDNA synthesis). The M-MLV reverse transcriptase from the Moloney murine leukemia virus is commonly used due to its reduced RNase H activity suited for transcription of longer RNAs. The AMV reverse transcriptase from the avian myeloblastosis virus may also be used for RNA templates with strong secondary structures (i.e. high melting temperature). cDNA is commonly generated from mRNA for gene expression analyses such as RT-qPCR and RNA-seq. mRNA is selectively reverse transcribed using oligo-dT primers that are the reverse complement of the poly-adenylated tail on the 3' end of all mRNA. An optimized mixture of oligo-dT and random hexamer primers increases the chance of obtaining full-length cDNA while reducing 5' or 3' bias. Ribosomal RNA may also be depleted to enrich both mRNA and non-poly-adenylated transcripts such as some non-coding RNA.
The result of first-strand syntheses, RNA-DNA hybrids, can be processed through multiple second-strand synthesis methods or processed directly in downstream assays. An early method known as hairpin-primed synthesis relied on hairpin formation on the 3' end of the first-strand cDNA to prime second-strand synthesis. However, priming is random and hairpin hydrolysis leads to loss of information. The Gubler and Hoffman Procedure uses E. Coli RNase H to nick mRNA that is replaced with E. Coli DNA Polymerase I and sealed with E. Coli DNA Ligase. An optimization of this procedure relies on low RNase H activity of M-MLV to nick mRNA with remaining RNA later removed by adding RNase H after DNA Polymerase translation of the second-strand cDNA. This prevents lost sequence information at the 5' end of the mRNA.
Complementary DNA is often used in gene cloning or as gene probes or in the creation of a cDNA library. When scientists transfer a gene from one cell into another cell in order to express the new genetic material as a protein in the recipient cell, the cDNA will be added to the recipient (rather than the entire gene), because the DNA for an entire gene may include DNA that does not code for the protein or that interrupts the coding sequence of the protein (e.g., introns). Partial sequences of cDNAs are often obtained as expressed sequence tags.
With amplification of DNA sequences via polymerase chain reaction (PCR) now commonplace, one will typically conduct reverse transcription as an initial step, followed by PCR to obtain an exact sequence of cDNA for intra-cellular expression. This is achieved by designing sequence-specific DNA primers that hybridize to the 5' and 3' ends of a cDNA region coding for a protein. Once amplified, the sequence can be cut at each end with nucleases and inserted into one of many small circular DNA sequences known as expression vectors. Such vectors allow for self-replication, inside the cells, and potentially integration in the host DNA. They typically also contain a strong promoter to drive transcription of the target cDNA into mRNA, which is then translated into protein.
cDNA is also used to study gene expression via methods such as RNA-seq or RT-qPCR. For sequencing, RNA must be fragmented due to sequencing platform size limitations. Additionally, second-strand synthesized cDNA must be ligated with adapters that allow cDNA fragments to be PCR amplified and bind to sequencing flow cells. Gene-specific analysis methods commonly use microarrays and RT-qPCR to quantify cDNA levels via fluorometric and other methods.
On 13 June 2013, the United States Supreme Court ruled in the case of Association for Molecular Pathology v. Myriad Genetics that while naturally occurring genes cannot be patented, cDNA is patent-eligible because it does not occur naturally.
Viruses and retrotransposons
Some viruses also use cDNA to turn their viral RNA into mRNA (viral RNA → cDNA → mRNA). The mRNA is used to make viral proteins to take over the host cell.
An example of this first step from viral RNA to cDNA can be seen in the HIV cycle of infection. Here, the host cell membrane becomes attached to the virus’ lipid envelope which allows the viral capsid with two copies of viral genome RNA to enter the host. The cDNA copy is then made through reverse transcription of the viral RNA, a process facilitated by the chaperone CypA and a viral capsid associated reverse transcriptase.
cDNA is also generated by retrotransposons in eukaryotic genomes. Retrotransposons are mobile genetic elements that move themselves within, and sometimes between, genomes via RNA intermediates. This mechanism is shared with viruses with the exclusion of the generation of infectious particles.
- cDNA library – Type of DNA library
- cDNA microarray – Collection of microscopic DNA spots attached to a solid surface
- RNA-Seq – Lab technique in cellular biology
- Real-time polymerase chain reaction – Laboratory technique of molecular biology (RT-qPCR)
Mark D. Adams et al. “Complementary DNA Sequencing: Expressed Sequence Tags and Human Genome Project.” Science (American Association for the Advancement of Science) 252.5013 (1991): 1651–1656. Web.
Philip M. Murphy, and H. Lee Tiffany. “Cloning of Complementary DNA Encoding a Functional Human Interleukin-8 Receptor.” Science (American Association for the Advancement of Science) 253.5025 (1991): 1280–1283. Web.
- ^ Hastings, P. J. (1 January 2001), "Complementary DNA (cDNA)", in Brenner, Sydney; Miller, Jefferey H. (eds.), Encyclopedia of Genetics, New York: Academic Press, p. 433, ISBN 978-0-12-227080-2, retrieved 29 November 2022
- ^ Croy, Ron. "Molecular Genetics II - Genetic Engineering Course (Supplementary notes)". Durham University durham.ac.uk; 20 April 1998. Archived from the original on 24 August 2002. Retrieved 4 February 2015.
- ^ Ying, Shao-Yao (1 July 2004). "Complementary DNA libraries". Molecular Biotechnology. 27 (3): 245–252. doi:10.1385/MB:27:3:245. ISSN 1559-0305. PMID 15247497. S2CID 25600775.
- ^ "5 Steps to Optimal cDNA Synthesis - US". www.thermofisher.com. Retrieved 12 May 2020.
- ^ Tavares, Lucélia; Alves, Paula M.; Ferreira, Ricardo B.; Santos, Claudia N. (6 January 2011). "Comparison of different methods for DNA-free RNA isolation from SK-N-MC neuroblastoma". BMC Research Notes. 4 (1): 3. doi:10.1186/1756-0500-4-3. ISSN 1756-0500. PMC 3050700. PMID 21211020.
- ^ R, Kansal; K, Kuhar; I, Verma; Rn, Gupta; Vk, Gupta; Kr, Koundal (December 2008). "Improved and Convenient Method of RNA Isolation From Polyphenols and Polysaccharide Rich Plant Tissues". Indian Journal of Experimental Biology. 46 (12): 842–5. PMID 19245182.
- ^ I, Vomelová; Z, Vanícková; A, Sedo (2009). "Methods of RNA Purification. All Ways (Should) Lead to Rome". Folia Biologica. 55 (6): 243–51. PMID 20163774.
- ^ Sellin Jeffries, Marlo K.; Kiss, Andor J.; Smith, Austin W.; Oris, James T. (14 November 2014). "A comparison of commercially-available automated and manual extraction kits for the isolation of total RNA from small tissue samples". BMC Biotechnology. 14 (1): 94. doi:10.1186/s12896-014-0094-8. ISSN 1472-6750. PMC 4239376. PMID 25394494.
- ^ "mRNA Isolation with Dynabeads in 15 minutes - US". www.thermofisher.com. Retrieved 20 May 2020.
- ^ Gaarz, Andrea; Debey-Pascher, Svenja; Classen, Sabine; Eggle, Daniela; Gathof, Birgit; Chen, Jing; Fan, Jian-Bing; Voss, Thorsten; Schultze, Joachim L.; Staratschek-Jox, Andrea (May 2010). "Bead Array–Based microRNA Expression Profiling of Peripheral Blood and the Impact of Different RNA Isolation Approaches". The Journal of Molecular Diagnostics. 12 (3): 335–344. doi:10.2353/jmoldx.2010.090116. ISSN 1525-1578. PMC 2860470. PMID 20228267.
- ^ Haddad, Fadia; Baldwin, Kenneth M. (2010), King, Nicola (ed.), "Reverse Transcription of the Ribonucleic Acid: The First Step in RT-PCR Assay", RT-PCR Protocols: Second Edition, Methods in Molecular Biology, Humana Press, vol. 630, pp. 261–270, doi:10.1007/978-1-60761-629-0_17, ISBN 978-1-60761-629-0, PMID 20301003
- ^ Martin, Karen. "Reverse Transcriptase & cDNA Overview & Applications". Gold Biotechnology. Retrieved 20 May 2020.
- ^ "qPCR, Microarrays or RNA Sequencing - What to Choose?". BioSistemika. 10 August 2017. Retrieved 20 May 2020.
- ^ "cDNA Synthesis | Bio-Rad". www.bio-rad.com. Retrieved 28 May 2020.
- ^ Herbert, Zachary T.; Kershner, Jamie P.; Butty, Vincent L.; Thimmapuram, Jyothi; Choudhari, Sulbha; Alekseyev, Yuriy O.; Fan, Jun; Podnar, Jessica W.; Wilcox, Edward; Gipson, Jenny; Gillaspy, Allison (15 March 2018). "Cross-site comparison of ribosomal depletion kits for Illumina RNAseq library construction". BMC Genomics. 19 (1): 199. doi:10.1186/s12864-018-4585-1. ISSN 1471-2164. PMC 6389247. PMID 29703133.
- ^ Invitrogen. "cDNA Synthesis System" (PDF). Thermofisher. Archived (PDF) from the original on 22 December 2018. Retrieved 27 May 2020.
- ^ Agarwal, Saurabh; Macfarlan, Todd S.; Sartor, Maureen A.; Iwase, Shigeki (21 January 2015). "Sequencing of first-strand cDNA library reveals full-length transcriptomes". Nature Communications. 6 (1): 6002. Bibcode:2015NatCo...6.6002A. doi:10.1038/ncomms7002. ISSN 2041-1723. PMC 5054741. PMID 25607527.
- ^ Derisi, J.; Penland, L.; Brown, P. O.; Bittner, M. L.; Meltzer, P. S.; Ray, M.; Chen, Y.; Su, Y. A.; Trent, J. M. (December 1996). "Use of a cDNA microarray to analyse gene expression patterns in human cancer". Nature Genetics. 14 (4): 457–460. doi:10.1038/ng1296-457. ISSN 1546-1718. PMID 8944026. S2CID 23091561.
- ^ White, Adam K.; VanInsberghe, Michael; Petriv, Oleh I.; Hamidi, Mani; Sikorski, Darek; Marra, Marco A.; Piret, James; Aparicio, Samuel; Hansen, Carl L. (23 August 2011). "High-throughput microfluidic single-cell RT-qPCR". Proceedings of the National Academy of Sciences. 108 (34): 13999–14004. Bibcode:2011PNAS..10813999W. doi:10.1073/pnas.1019446108. ISSN 0027-8424. PMC 3161570. PMID 21808033.
- ^ Hrdlickova, Radmila; Toloue, Masoud; Tian, Bin (January 2017). "RNA-Seq methods for transcriptome analysis". Wiley Interdisciplinary Reviews. RNA. 8 (1): e1364. doi:10.1002/wrna.1364. ISSN 1757-7004. PMC 5717752. PMID 27198714.
- ^ Liptak, Adam (13 June 2013). "Supreme Court Rules Human Genes May Not Be Patented". The New York Times. Archived from the original on 1 January 2022. Retrieved 14 June 2013.
- ^ Altfeld, Marcus; Gale, Michael Jr. (1 June 2015). "Innate immunity against HIV-1 infection". Nature Immunology. 16 (6): 554–562. doi:10.1038/ni.3157. ISSN 1529-2908. PMID 25988887. S2CID 1577651.
- ^ Havecker, Ericka R.; Gao, Xiang; Voytas, Daniel F. (18 May 2004). "The diversity of LTR retrotransposons". Genome Biology. 5 (6): 225. doi:10.1186/gb-2004-5-6-225. ISSN 1474-760X. PMC 463057. PMID 15186483.
- ^ Cordaux, Richard; Batzer, Mark A. (October 2009). "The impact of retrotransposons on human genome evolution". Nature Reviews Genetics. 10 (10): 691–703. doi:10.1038/nrg2640. ISSN 1471-0064. PMC 2884099. PMID 19763152.